 Biotech company Addison Bio is revealing that the FDA has granted fast-track designation to its potential treatment for a certain type of cancer. ADI-270 is intended to treat patients with metastatic advanced clear cell renal cell carcinoma. Despicable Me soared to the top of the box office over the weekend. Erin Real has details.